2/29
06:06 am
tars
Rating for TARS
Low
Report
Rating for TARS
2/29
06:06 am
tars
Rating for TARS
Low
Report
Rating for TARS
2/29
06:06 am
tars
Rating for TARS
Low
Report
Rating for TARS
2/28
11:15 am
tars
Rating for TARS
Low
Report
Rating for TARS
2/28
11:15 am
tars
Rating for TARS
Low
Report
Rating for TARS
2/28
08:17 am
tars
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $59.00 price target on the stock, up previously from $55.00.
Low
Report
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $59.00 price target on the stock, up previously from $55.00.
2/28
07:47 am
tars
Rating for TARS
Low
Report
Rating for TARS
2/28
07:47 am
tars
Rating for TARS
Low
Report
Rating for TARS